These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9591584)

  • 41. Biological dosimetry after total body irradiation (TBI) for hematologic malignancy patients.
    Dossou J; Lartigau E; M'Kacher R; Légal JD; Bridier A; Guichard M; Eschwege F; Parmentier C
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):123-9. PubMed ID: 10656383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytogenetic Damage Induced by Radioiodine Therapy: A Follow-Up Case Study.
    Khvostunov IK; Nasonova E; Krylov V; Rodichev A; Kochetova T; Shepel N; Korovchuk O; Kutsalo P; Shegai P; Kaprin A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma.
    Verburg FA
    Q J Nucl Med Mol Imaging; 2019 Sep; 63(3):253-257. PubMed ID: 31271272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Shielding effect of distance in (131)I-131 therapy for differentiated thyroid cancer].
    Chi X; Liu F; Li G; Wang Q; Deng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):286-8. PubMed ID: 24589615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of physical and cytogenetic estimates of radiation dose in patients treated with iodine-131 for thyroid carcinoma.
    Llloyd DC; Purrott RJ; Dolphin GW; Horton PW; Halnan KE; Scott JS; Mair G
    Int J Radiat Biol Relat Stud Phys Chem Med; 1976 Nov; 30(5):473-85. PubMed ID: 1087288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytogenetic study of radiation burden in thyroid disease patients treated with external irradiation or radioiodine.
    Gundy S; Katz N; Füzy M; Esik O
    Mutat Res; 1996 Jun; 360(2):107-13. PubMed ID: 8649463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitive immunodetection of radiotoxicity after iodine-131 therapy for thyroid cancer using γ-H2AX foci of DNA damage in lymphocytes.
    Doai M; Watanabe N; Takahashi T; Taniguchi M; Tonami H; Iwabuchi K; Kayano D; Fukuoka M; Kinuya S
    Ann Nucl Med; 2013 Apr; 27(3):233-8. PubMed ID: 23264066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Iodine-131 treatment and chromosomal damage: in vivo dose-effect relationship.
    Erselcan T; Sungu S; Ozdemir S; Turgut B; Dogan D; Ozdemir O
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):676-84. PubMed ID: 14747958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioactive iodine induces clastogenic and age-dependent aneugenic effects in lymphocytes of thyroid cancer patients as revealed by interphase FISH.
    Ramírez MJ; Surrallés J; Galofré P; Creus A; Marcos R
    Mutagenesis; 1997 Nov; 12(6):449-55. PubMed ID: 9412999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 131I activity in urine to the sewer system due to thyroidal treatments.
    Andrés C; Barquero R; Tortosa R; Nuñez C; del Castillo A; Vega-Carrillo HR; Alonso D
    Health Phys; 2011 Aug; 101 Suppl 2():S110-5. PubMed ID: 21709491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chromosomal changes following irradiation with small doses (author's transl)].
    Zsebök Z; Baumgartner E
    Rofo; 1978 Dec; 129(6):781-4. PubMed ID: 153284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implementation of a card with instructions for patients treated for thyroid carcinoma with 131I.
    Mínguez P; Genolla J; Fombellida JC
    Radiat Prot Dosimetry; 2012 Aug; 151(1):76-80. PubMed ID: 22232772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Dosimetric characteristics of internal irradiation with radioactive nuclides of iodine].
    Stepanenko VF; Norets TA; Dedov VI
    Med Radiol (Mosk); 1987 Jun; 32(6):45-9. PubMed ID: 3600224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible transient adaptive response to mitomycin C in peripheral lymphocytes from thyroid cancer patients after iodine-131 therapy.
    Monteiro Gil O; Oliveira NG; Rodrigues AS; Laires A; Ferreira TC; Limbert E; Rueff J
    Int J Cancer; 2002 Dec; 102(6):556-61. PubMed ID: 12447995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chromosome aberration analysis as a dosimetric technique in radiological protection.
    Dolphin GW; Lloyd DC; Purrott RJ
    Health Phys; 1973 Jul; 25(1):7-15. PubMed ID: 4785405
    [No Abstract]   [Full Text] [Related]  

  • 56. Alternative Means of Estimating
    Nichols KJ; Robeson W; Yoshida-Hay M; Zanzonico PB; Leveque F; Bhargava KK; Tronco GG; Palestro CJ
    J Nucl Med; 2017 Oct; 58(10):1588-1595. PubMed ID: 28408530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cytogenetic research on the blood lymphocytes of rats exposed separately and jointly to 45Ca and 131I].
    Monakhov AS
    Radiobiologiia; 1988; 28(3):381-4. PubMed ID: 3399640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cytogenetic and blastomogenic effects of 45Ca and 131I administered to rats].
    Monakhov AS
    Eksp Onkol; 1988; 10(4):27-30. PubMed ID: 3181072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Estimation of absorbed dose in 131I therapy of metastasis of thyroid cancer].
    Takai M; Sugiyama A; Sakamoto S; Kaneko M
    Radioisotopes; 1988 Dec; 37(12):677-80. PubMed ID: 3252360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Radiation risk during radionuclide diagnosis of thyroid diseases].
    Iakovleva NG
    Med Radiol (Mosk); 1986 Feb; 31(2):46-8. PubMed ID: 3951348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.